Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
07/13/2000 | CA2360396A1 Characterization of a calcium channel family |
07/13/2000 | CA2358754A1 Synergistic tumorcidal response induced by histamine |
07/13/2000 | CA2356937A1 Recombinant herpes simplex virus useful for treating neoplastic disease |
07/13/2000 | CA2356434A1 Non-myeloablative tolerogenic treatment |
07/13/2000 | CA2356401A1 Expression and export of anti-obesity proteins as fc fusion proteins |
07/13/2000 | CA2355967A1 Astrocytes, their preparation and uses thereof |
07/13/2000 | CA2355859A1 Gene therapy-1 |
07/13/2000 | CA2354638A1 Expression of secreted human alpha-fetoprotein in transgenic animals |
07/13/2000 | CA2354194A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
07/12/2000 | EP1018557A2 Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
07/12/2000 | EP1017838A2 Expression of genes in hematopoietic stem cells in hischaemic conditions |
07/12/2000 | EP1017837A1 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site |
07/12/2000 | EP1017836A2 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
07/12/2000 | EP1017815A1 Murine model for human carcinoma |
07/12/2000 | EP1017807A1 Osf2/cbfa1 compositions and methods of use |
07/12/2000 | EP1017789A1 Nucleic acid encoding a lectin-derived progenitor cell preservation factor |
07/12/2000 | EP1017723A2 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use |
07/12/2000 | EP1017423A1 Cloning pigs using donor nuclei from differentiated cells |
07/12/2000 | EP1017422A1 Cloning using donor nuclei from non-serum starved, differentiated cells |
07/12/2000 | EP1017406A1 Bovine excretion extracts having anticancer and anti-inflammatory activity and process for preparing the same |
07/12/2000 | EP0901405A4 Fibrinogen apparatus, method and container |
07/12/2000 | EP0610345B1 Combined cellular and immunosuppressive therapies |
07/12/2000 | EP0584228B1 A method of producing thermoplastic polymeric material |
07/12/2000 | CN1260046A Prenatal diagnostic methods |
07/12/2000 | CN1259874A Vaginal lactobacillus medicant |
07/12/2000 | CN1259873A Bio-pharmaceutical prepn. contg. live culture of bacillus and method treating viral and bacterial infection as well as immuno-deficiency conditions |
07/12/2000 | CN1259872A NKT cell activators contg. alpha-glycosylceramides |
07/12/2000 | CN1259523A Immuno active polypeptide for treating psoriasis and its prepn. method |
07/12/2000 | CN1259384A Bone strengthening powder made of yak marrow and its processing method |
07/12/2000 | CN1259376A Medicinal liquid for treating bone fracture |
07/12/2000 | CN1259371A Medicinal drops for treating dental caries |
07/12/2000 | CN1259369A Medicine for treating rigid spine inflammation and prepn. method thereof |
07/12/2000 | CN1259368A Medicine for treating gastritis, gastric ulcer and duodenal ulcer and its prepn. method |
07/12/2000 | CN1259367A Traditional Chinese medicinal pill for transforming calculus, eliminating toxin and anti tumour |
07/12/2000 | CN1259366A Traditional Chinese medicinal pill benefiting kidney and primordial energy |
07/12/2000 | CN1259362A Medicine for treating haemorrhoids and anal fistula radically |
07/12/2000 | CN1259360A Medicine for treating pulmonary hart diseases |
07/12/2000 | CN1259354A External use medicinal liquid for treating psoriasis |
07/12/2000 | CN1259353A Animal cartilage health-care capsule for inhibiting tumour growth, eliminating free radical and anti peroxidation of lipid and prepn. method thereof |
07/12/2000 | CN1259352A Whole deer prepn. |
07/12/2000 | CN1054292C Chinese proprietary medicine for treating hemiplegia |
07/12/2000 | CN1054291C Plaster for treating spur and cervical spondylopathy |
07/12/2000 | CN1054290C Chinese herb medicine prepn. for treating prostate hyperplasia and its preparing method |
07/12/2000 | CN1054289C Medicine for curing tumour |
07/12/2000 | CN1054288C Application plaster for treating cancer pain |
07/12/2000 | CN1054285C Quick bone-setting medicinal powder |
07/12/2000 | CN1054283C Ionic type skin care powder |
07/11/2000 | US6087487 Cdna molecule encoding a protein having nap domains and factor xa inhibitory activity; for in vitro diagnostic agents; in vivo therapy |
07/11/2000 | US6087370 Methods of treatment using lamellarin-class alkaloids |
07/11/2000 | US6087323 Use of neuregulins as modulators of cellular communication |
07/11/2000 | US6087178 Method for down regulating CD4 expression in a T cell |
07/11/2000 | US6087168 Obtaining basal epidermal cells, transfecting with expression vectors coding for neurogenic transcription factors, adding antisense oligonucleotide to suppress negative regulators of neuronal differentiation, culturing with retinoid and factors |
07/11/2000 | US6087150 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4 |
07/11/2000 | US6087113 Recovering mammalian bone marrow aggregations from mixture; incubation of aggregations with preferential immunoglobulin, recovering immunoglobulin bound aggregations |
07/11/2000 | US6087110 Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein |
07/11/2000 | US6087087 Treatment of hemoglobin with nitric oxide |
07/11/2000 | US6086894 Recombinant vaccine for diseases caused by encapsulated organisms |
07/11/2000 | US6086891 Plasmids |
07/11/2000 | US6086884 Composition for treating impotence in men containing dried roe and yohimbine |
07/11/2000 | US6086878 By administering a gastrointestinal neuromodulator antibody, such as antibodies to bombesin, cholecystokinin, gastrin, somatostatin, and neuropeptide y; for egg or milk-producing animals |
07/11/2000 | US6086770 Venting system |
07/11/2000 | US6086552 Treatment of chronic post-traumatic pain syndromes |
07/06/2000 | WO2000039588A1 Detection of preactivated phagocytes |
07/06/2000 | WO2000039311A1 Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 |
07/06/2000 | WO2000039304A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
07/06/2000 | WO2000039283A1 Use of cd40 engagement to alter t cell receptor usage |
07/06/2000 | WO2000039275A2 Multiple shear stress responsive elements (ssre) and methods of use thereof |
07/06/2000 | WO2000039146A1 Miniribozymes active at low magnesium ion concentrations |
07/06/2000 | WO2000039145A1 Targeted gene transfer using g protein coupled receptors |
07/06/2000 | WO2000039136A2 Human brainiac-5 |
07/06/2000 | WO2000039135A2 Insulin mimetics from honey |
07/06/2000 | WO2000038747A2 Absorbent article composition and method of use for sequestering skin irritants |
07/06/2000 | WO2000038743A1 Removal of biological contaminants |
07/06/2000 | WO2000038737A2 GENE THERAPY FOR PULMONARY EDEMA USING ADENOVIRUS VECTORS ENCODING Na,K-ATPase |
07/06/2000 | WO2000038708A1 Treatment and prevention of immune rejection reactions |
07/06/2000 | WO2000038698A2 Substances from porcine tissue |
07/06/2000 | WO2000038658A1 Spray-type cosmetic composition and matrix used in said composition for dermal administration |
07/06/2000 | WO2000038626A2 Substrate composition and method of use for sequestration of skin irritants |
07/06/2000 | WO2000038625A2 Facial tissue composition and method of use for sequestration of nasal secretion skin irritants |
07/06/2000 | WO2000038535A1 Food-induced antisecretory proteins in egg yolk |
07/06/2000 | WO2000038518A1 Efficient and stable (in vivo) gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors |
07/06/2000 | WO2000038517A1 Methods for reducing adverse side effects associated with cellular transplantation |
07/06/2000 | WO2000038515A1 Peptide mimics useful for treating disease |
07/06/2000 | CA2358385A1 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
07/06/2000 | CA2358094A1 Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 |
07/06/2000 | CA2356894A1 Removal of biological contaminants |
07/06/2000 | CA2356877A1 Gene therapy for pulmonary edema using adenovirus vectors encoding na,k-atpase |
07/06/2000 | CA2356834A1 Methods for reducing adverse side effects associated with cellular transplantation |
07/06/2000 | CA2356551A1 Efficient and stable in vivo gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors |
07/06/2000 | CA2356548A1 Human brainiac-5 |
07/06/2000 | CA2355227A1 Targeted gene transfer using g protein coupled receptors |
07/06/2000 | CA2350685A1 Spray-type cosmetic composition and matrix used in said composition for dermal administration |
07/06/2000 | CA2334958A1 Peptide mimics useful for treating disease |
07/05/2000 | EP1016673A1 Composition comprising coagulation factor VIII formulation, process for its preparation and use of a surfactant as stabilizer |
07/05/2000 | EP1016418A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
07/05/2000 | EP1016413A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
07/05/2000 | EP1015826A2 Long-term shelf preservation by vitrification |
07/05/2000 | EP1015615A1 Targeted gene transfer using g protein coupled receptors |
07/05/2000 | EP1015602A1 Glutrna gln amidotransferase - a novel essential translational component |
07/05/2000 | EP1015572A2 Nuclear transfer with differentiated fetal and adult donor cells |